Skip to main content

Education/ACR/EULAR

Inflammatory bowel disease in spondyloarthritis - does it matter?

Do the clinical features of axSpA patients with and without IBD differ?

In Abstract OP0085 at #EULAR2024, De Hooge M et al presented data from the METEOR cohort that identify clinical differences between these two groups. This will be important in order to stratify the management approach

Read Article
New hypothesis are explored in #Sjogren #EULAR2024 CB https://t.co/0glF5BGVO5
Annals of the Rheumatic Diseases @ARD_BMJ( View Tweet )
Computer vision/ image analysis is performing very well in rheumatology and can extend help to low resource settings easily! #EULAR2024 https://t.co/8doM7foriM
Bella Mehta @bella_mehta( View Tweet )
Deep learning models are detecting CPPD in radiographs pretty well!! Abst#0112 #EULAR2024 presented by @ThomasHugle ...@RheumNow https://t.co/9z3VVbyyh0
Bella Mehta @bella_mehta( View Tweet )

Can we withdraw treatment in post-menopausal osteoporosis?

EurekAlert!

Analysis of French claims data, found over half of women initiating oral bisphosphonates (BP) between 2015 and 2020 discontinued treatment for at least one year, which was associated with a 12% increase in fracture risk. While not recommended, 42.5% of women initiating Dmab discontinued

Read Article
Still a long way but fascinating re: computer vision of hand movement from @vincevenerito @ThomasHugle. Proof of concept training set shows decent correlation with DAS28-LDA & HAQ-DI. Much more work needed but the promise for telehealth is enticing #EULAR2024 POS0607 @RheumNow https://t.co/iXsdn9fvuH
David Liew @drdavidliew( View Tweet )
Elegant talk of #interferon #gamma in #pyoderma #gangrenosum Vs #PG + #pyogenic #arthritis +#acne #autoinflammatory #syndromes #Papa syn IL18 differences between PG alone and together in syndrome #JAKi May be helpful #EULAR2024 @eular_org @RheumNow @ARD_BMJ @ACR_Journals https://t.co/plYldVdolS
Janet Pope @Janetbirdope( View Tweet )
I think you can guess why in the USA many Pts with #immunesuppressives In #chronic #diseases? IT IS the 💵 cost of #medications in uninsured pts #EULAR2024 @RheumNow @ACRheum @eular_org A call for #equitable #fair #pharmacare #EULARBEST https://t.co/VRnmKrf3DZ
Janet Pope @Janetbirdope( View Tweet )

Belimumab’s Sustained Impact in Lupus

In the wake of the EULAR 2023 guidelines on the management of SLE, it is perhaps pertinent that the EULAR 2024 congress features three abstracts from a large integrated analysis from five international Phase 3 belimumab trials in adults with active SLE (BLISS-76, BLISS-52, North East Asia,

Read Article
#EULAR2024 OP0076 UK multicentre cohort study showed rituximab was effective in systemic features of #Sjogren in children & adults. One in 6 lost response in subsequent cycle due to antidrug antibodies. Humanised or type 2 antiCD20Ab in the future could improve this @RheumNow https://t.co/duYpr2yKGB
Md Yuzaiful Md Yusof @Yuz6Yusof( View Tweet )

EULAR 2024 - Day 1 Report

Wednesday was Day One at EULAR 2024 in Vienna. While the day was a slow start, the poster halls and auditoriums quickly filled with thousands of rheumatologists, eager to reunite at this international educational forum. Below are a few of my favorites from Day 1.

Read Article

Can we prevent psoriatic arthritis?

Psoriatic arthritis (PsA) can affect up to 30% of patients with psoriasis (PsO). Understanding the factors that predispose patients with PsO who progress to PsA is the first step in understanding how early interventions in PsO may augment the progression to PsA. At #EULAR2024, there are a few

Read Article

EULAR 2024: New drugs for RA?

Several abstracts are presenting new compounds, targeting either RA well-known inflammatory pathways or offering new mechanisms of action or therapeutic sequences; these are summarized below.

Read Article
Digital biomarkers are also going to be useful int he future - from devices such as phone / watches.

Bella Mehta @bella_mehta( View Tweet )

Final prep in my hotel room for tomorrow’s big #EULAR2024 opening debate: this David up against the metaphorical (if not physical) Goliath, @Janetbirdope. Data does not adequately justify this JAKi regulatory safety warning, tomorrow I’ll tell you why. Details below ⬇️ @RheumNow https://t.co/rwFtYRlpLY
David Liew @drdavidliew( View Tweet )

AI meets Rheumatology: ChatGPT and patient response optimization

Large language models, such as ChatGPT, are advanced systems trained on vast amounts of text data, far exceeding what a human can read in a lifetime, to understand and generate human-like language. With these tools at our disposal, they are inevitably making their way into healthcare. One

Read Article
✨ Powerful stories shared at the #EULAR2024 Opening Ceremony including from #PARE Chair @fibrofella https://t.co/Jzfk9LrhV4

Mrinalini Dey @DrMiniDey( View Tweet )

Asking the quintessential Australian question at #EULAR24 by @drdavidliew - does the ORAL surveillance study for JAKi *truly* pass the pub test? @eular_org @Janetbirdope @RheumNow What does #MedTwitter think? https://t.co/bqwPU8XX5S
Benjamin Sutu @benjaminsutu( View Tweet )
Join us later for a some very exciting pieces of translational science across a AIRDs. All these abstracts sharing one thing in common: tissue, tissue, tissue! 16:30-18:00 Room A8.2 @RheumNow #EULAR2024 https://t.co/HrHP5tmHDD
Aurelie Najm @AurelieRheumo( View Tweet )
Dr. D Aletaha defines The #EULARManifesto, "It is about patient centeredness-- improving quality of care, advocating for patients, timely access to specialists, pushing R&D innovation, integrating technology to make sure every patient gets the care they need." @rheumnow #EULAR24

TheDaoIndex @KDAO2011( View Tweet )

LONG-TERM EFFICACY TOCILIZUMAB AFTER ULTRA-SHORT GC TO TREAT GCA: 3 Yr FOLLOW-UP OF THE GUSTO TRIAL 3 day GC pulse immediate 12 mths Toci 85% drug free remission at 4 yrs! @rheumnow #EULAR2024

Peter Nash @drpnash( View Tweet )

SLE Preview: abolishing refractory with CAR-T and better B-cell therapies

Inhibition of B cell activating factor (BAFF) and B cell depletion are the two most evaluated strategies over the last 15 years in the field of SLE therapeutics, with licensing of belimumab and off-label use of rituximab. Despite this, some patients remain refractory to these

Read Article
#EULAR2024 Opening Ceremony. @DanielAletaha highlighted values of @eular strategies that have been achieved: Patient centredness ✔️ Innovation ✔️ - RheumaFacts, ENTRI, Exams Inclusivity ✔️ To strive on 3 other values by next year under President-Elect @XBaraliakos @RheumNow https://t.co/wDR2vtv3I2
Md Yuzaiful Md Yusof @Yuz6Yusof( View Tweet )
📄 #EULARAdvocacy Chair @carmona_loreto discusses the @eular_org manifesto at the #EULAR2024 opening ceremony 🔗You can read the full manifesto and find out more here: https://t.co/6CZuSYpiLl @RheumNow https://t.co/DYcU9I6rmR
Mrinalini Dey @DrMiniDey( View Tweet )
« We must work together to achieve a future where RMDs are no longer an invisible problem » Wise words from @carmona_loreto during Opening Plenary session #EULAR2024 @RheumNow

Aurelie Najm @AurelieRheumo( View Tweet )